Renalytix (Renalytix) Inventories, Finished Goods : $0.00 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Renalytix Inventories, Finished Goods?

Renalytix's quarterly finished goods increased from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($0.51 Mil) but then declined from Dec. 2023 ($0.51 Mil) to Mar. 2024 ($0.00 Mil).

Renalytix's annual finished goods increased from Jun. 2021 ($0.35 Mil) to Jun. 2022 ($1.16 Mil) but then declined from Jun. 2022 ($1.16 Mil) to Jun. 2023 ($0.00 Mil).

Renalytix Inventories, Finished Goods Historical Data

The historical data trend for Renalytix's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renalytix Inventories, Finished Goods Chart

Renalytix Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Inventories, Finished Goods

Get a 7-Day Free Trial

0.33

0.35

1.16

Renalytix Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Inventories, Finished Goods	Get a 7-Day Free Trial															-	-	-	0.51	-

Renalytix Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Renalytix (Renalytix) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Renalytix PLC (OTCPK:RTNXF) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

RNLX:USA RENX:UK 2O9:Germany

Address

5-7 Cranwood Street, Finsgate, London, GBR, EC1V 9EE

Website

https://www.renalytix.com

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.